Free Trial

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

Quest Diagnostics logo
$177.08 +2.82 (+1.62%)
Closing price 03:59 PM Eastern
Extended Trading
$176.97 -0.12 (-0.06%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics Earnings Summary

Quest Diagnostics posted Q2 2025 earnings on July 22, 2025, reporting an EPS of $2.62, which topped analysts' consensus estimates of $2.57 by $0.05. Quarterly revenue rose 15.2% year-over-year to $2.76 billion, above analyst estimates of $2.73 billion. With a trailing EPS of $8.35 and a P/E Ratio of 21.21, Quest Diagnostics' earnings are expected to grow 8.14% next year, from $9.70 to $10.49 per share.

Latest Q2
Earnings Date
Jul. 22Estimated
Consensus EPS
(Jul. 22)
$2.57
Actual EPS
(Jul. 22)
$2.62 Beat By $0.05
Actual Revenue
(Jul. 22)
$2.76B

Q2 2025 Earnings Resources

Get Quest Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20253$2.11$2.19$2.16
Q2 20253$2.43$2.56$2.51
Q3 20253$2.50$2.53$2.51
Q4 20253$2.40$2.44$2.42
FY 2025 12 $9.44 $9.72 $9.60
Q1 20262$2.36$2.39$2.38
Q2 20262$2.68$2.93$2.81
Q3 20262$2.70$2.73$2.72
Q4 20262$2.48$2.68$2.58
FY 2026 8 $10.22 $10.73 $10.48
Q1 20271$2.62$2.62$2.62

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025$2.57$2.62+$0.05$2.47$2.73B$2.76B
4/22/2025Q1 2025$2.15$2.21+$0.06$1.94$2.63B$2.65B
1/30/2025Q4 2024$2.19$2.23+$0.04$1.95$2.58B-
10/22/2024Q3 2024$2.26$2.30+$0.04$2.61$2.43B$2.49B
7/23/2024Q2 2024$2.31$2.35+$0.04$2.67$2.39B$2.40B
4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29B$2.37B
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25B$2.29B
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27B$2.30B

Quest Diagnostics Earnings - Frequently Asked Questions

Quest Diagnostics (NYSE:DGX) last announced its quarterly earning data on Tuesday, July 22, 2025. Learn more on DGX's earnings history.

Quest Diagnostics updated its FY 2025 earnings guidance on Tuesday, July, 22nd. The company provided earnings per share guidance of 9.630-9.830 for the period, compared to the consensus EPS estimate of 9.696. The company issued revenue guidance of $10.8 billion-$10.9 billion, compared to the consensus revenue estimate of $10.8 billion.

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.62 earnings per share (EPS) to beat the analysts' consensus estimate of $2.57 by $0.05. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

The conference call for Quest Diagnostics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Quest Diagnostics' latest earnings report can be read online.
Read Transcript

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.87 billion.

Quest Diagnostics (NYSE:DGX) has a recorded net income of $871 million. DGX has generated $8.35 earnings per share over the last four quarters.

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 21.21 and a forward price-to-earnings ratio of 18.26. The price/earnings-to-growth ratio is 2.3.

Quest Diagnostics' earnings are expected to grow from $9.70 per share to $10.49 per share in the next year, which is a 8.14% increase.

More Earnings Resources from MarketBeat



This page (NYSE:DGX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners